These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 5753681)

  • 21. Colorimetric heparinase assay for alternative anti-metastatic activity.
    Ahn SC; Kim BY; Oh WK; Park YM; Kim HM; Ahn JS
    Life Sci; 2006 Sep; 79(17):1661-5. PubMed ID: 16806278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo activity of microbial heparinase.
    Langer R; Linhardt RJ; Larsen AK; Cooney CL; Tapper D; Klein M
    Trans Am Soc Artif Intern Organs; 1982; 28():387-90. PubMed ID: 7164268
    [No Abstract]   [Full Text] [Related]  

  • 23. Heparinase: in vivo activity and immunogenicity in rabbits.
    Klein MD; Drongowski RA; Linhardt RJ; Cooney CL; Langer RS
    J Lab Clin Med; 1983 Nov; 102(5):828-37. PubMed ID: 6631173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MICRO-ELECTROPHORESIS OF HEPARIN.
    JAQUES LB; BALLIEUX RE; VAN ARKEL
    Acta Med Scand; 1963 Dec; 174():717-24. PubMed ID: 14089262
    [No Abstract]   [Full Text] [Related]  

  • 25. Substrate specificity of the heparin lyases from Flavobacterium heparinum.
    Desai UR; Wang HM; Linhardt RJ
    Arch Biochem Biophys; 1993 Nov; 306(2):461-8. PubMed ID: 8215450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Heparin].
    Yoshizawa Z
    Tanpakushitsu Kakusan Koso; 1969 May; 14(6):595-603. PubMed ID: 4896770
    [No Abstract]   [Full Text] [Related]  

  • 27. Engineering of an FGF-proteoglycan fusion protein with heparin-independent, mitogenic activity.
    Yoneda A; Asada M; Oda Y; Suzuki M; Imamura T
    Nat Biotechnol; 2000 Jun; 18(6):641-4. PubMed ID: 10835602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin.
    Bitan M; Mohsen M; Levi E; Wygoda MR; Miao HQ; Lider O; Svahn CM; Ekre HP; Ishai-Michaeli R; Bar-Shavit R
    Isr J Med Sci; 1995; 31(2-3):106-18. PubMed ID: 7744578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of tumor metastasis by heparanase inhibiting species of heparin.
    Vlodavsky I; Mohsen M; Lider O; Svahn CM; Ekre HP; Vigoda M; Ishai-Michaeli R; Peretz T
    Invasion Metastasis; 1994-1995; 14(1-6):290-302. PubMed ID: 7657522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparinase. III. Preparation and properties of the enzyme.
    CHO MH; JAQUES LB
    Can J Biochem Physiol; 1956 Jul; 34(4):799-813. PubMed ID: 13343042
    [No Abstract]   [Full Text] [Related]  

  • 31. A new type of heparin "omega-heparin" isolated from whale organs.
    Yosizawa Z
    Biochem Biophys Res Commun; 1964 Jul; 16(4):336-41. PubMed ID: 5871818
    [No Abstract]   [Full Text] [Related]  

  • 32. Bacterial degradation of heparin.
    PAYZA AN; KORN ED
    Nature; 1956 Jan; 177(4498):88-9. PubMed ID: 13288602
    [No Abstract]   [Full Text] [Related]  

  • 33. The degradation of heparin by bacterial enzymes. II. Acetone powder extracts.
    KORN ED; PAYZA AN
    J Biol Chem; 1956 Dec; 223(2):859-64. PubMed ID: 13385233
    [No Abstract]   [Full Text] [Related]  

  • 34. Heparin fractionation by electrofocusing: presence of 21 components of different molecular weights.
    Nader HB; McDuffie NM; Dietrich CP
    Biochem Biophys Res Commun; 1974 Mar; 57(2):488-93. PubMed ID: 4829406
    [No Abstract]   [Full Text] [Related]  

  • 35. The degradation of heparin by bacterial enzymes. I. Adaptation and lyophilized cells.
    KORN ED; PAYZA AN
    J Biol Chem; 1956 Dec; 223(2):853-8. PubMed ID: 13385232
    [No Abstract]   [Full Text] [Related]  

  • 36. [Concerning diverse applications of a heparinmucopolysaccharidase combination].
    MARY C
    Clinique (Paris); 1963 Feb; 57():128-30. PubMed ID: 13933230
    [No Abstract]   [Full Text] [Related]  

  • 37. [Degradation of heparin by bacterial heparinase].
    Yamaha T; Takahashi T; Kimura T
    Eisei Shikenjo Hokoku; 1968; 86():36-40. PubMed ID: 5753681
    [No Abstract]   [Full Text] [Related]  

  • 38. Isolation and characterization of oligosaccharides obtained from heparin by the action of heparinase.
    Linker A; Hovingh P
    Biochemistry; 1972 Feb; 11(4):563-8. PubMed ID: 5062409
    [No Abstract]   [Full Text] [Related]  

  • 39. Enzymic degradation of omega-heparin (whale heparin).
    Yosizawa Z
    Biochim Biophys Acta; 1967 Aug; 141(3):600-4. PubMed ID: 6049518
    [No Abstract]   [Full Text] [Related]  

  • 40. The enzymatic degradation of heparin and heparitin sulfate. 3. Purification of a heparitinase and a heparinase from flavobacteria.
    Hovingh P; Linker A
    J Biol Chem; 1970 Nov; 245(22):6170-5. PubMed ID: 5484472
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.